SCANDINAV. REAL HEART AB
Scandinavian Real Heart AB (Publ) designs and develops an artificial heart. The company engages in developing Realheart TAH to treat advanced stage heart failure. It also develops RealVAD, pulsating left ventricle assist; PulsePump, pulsating flow for heart and lung machines; and Sternal Prosthesis, to fix the sternum after open-chest surgery. The company was incorporated in 2007 and is based in … Read more
Market Cap & Net Worth: SCANDINAV. REAL HEART AB (782)
SCANDINAV. REAL HEART AB (F:782) has a market capitalization of $3.22 Million (€3.14 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #43000 globally and #6827 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SCANDINAV. REAL HEART AB's stock price €1.52 by its total outstanding shares 2068150 (2.07 Million).
SCANDINAV. REAL HEART AB Market Cap History: 2015 to 2024
SCANDINAV. REAL HEART AB's market capitalization history from 2015 to 2024. Data shows growth from $120.16K to $3.22 Million (44.25% CAGR).
SCANDINAV. REAL HEART AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SCANDINAV. REAL HEART AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 782 by Market Capitalization
Companies near SCANDINAV. REAL HEART AB in the global market cap rankings as of March 19, 2026.
Key companies related to SCANDINAV. REAL HEART AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
SCANDINAV. REAL HEART AB Historical Marketcap From 2015 to 2024
Between 2015 and today, SCANDINAV. REAL HEART AB's market cap moved from $120.16K to $ 3.22 Million, with a yearly change of 44.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | €3.22 Million | -51.33% |
| 2023 | €6.61 Million | -70.23% |
| 2022 | €22.21 Million | +19717.80% |
| 2021 | €112.09K | +15.03% |
| 2020 | €97.44K | -10.53% |
| 2019 | €108.90K | +0.79% |
| 2018 | €108.06K | -22.64% |
| 2017 | €139.69K | +97.01% |
| 2016 | €70.90K | -40.99% |
| 2015 | €120.16K | -- |
End of Day Market Cap According to Different Sources
On Nov 27th, 2025 the market cap of SCANDINAV. REAL HEART AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.22 Million USD |
| MoneyControl | $3.22 Million USD |
| MarketWatch | $3.22 Million USD |
| marketcap.company | $3.22 Million USD |
| Reuters | $3.22 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.